1924
M.P. Kötzler et al. / Biochimica et Biophysica Acta 1820 (2012) 1915–1925
[
4] X. Wang, J. Gu, H. Ihara, E. Miyoshi, K. Honke, N. Taniguchi, Core fucosylation reg-
ulates epidermal growth factor receptor-mediated intracellular signaling, J. Biol.
4
.4. Comparison to α1,3 fucosyltransferase of H. pylori
Chem. 281 (2006) 2572–2577.
Substrate recognition and the catalytic mechanism of FUT8 are sig-
[5] X. Wang, S. Inoue, J. Gu, E. Miyoshi, K. Noda, W. Li, Y. Mizuno-Horikawa, M. Nakano,
M. Asahi, M. Takahashi, N. Uozumi, S. Ihara, S.H. Lee, Y. Ikeda, Y. Yamaguchi, Y. Aze, Y.
Tomiyama, J. Fujii, K. Suzuki, A. Kondo, S.D. Shapiro, C. Lopez-Otin, T. Kuwaki, M.
Okabe, K. Honke, N. Taniguchi, Dysregulation of TGF-β1 receptor activation leads
to abnormal lung development and emphysema-like phenotype in core
fucose-deficient mice, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15791–15796.
6] X. Wang, T. Fukuda, W. Li, C.X. Gao, A. Kondo, A. Matsumoto, E. Miyoshi, N.
Taniguchi, J. Gu, Requirement of Fut8 for the expression of vascular endothelial
growth factor receptor-2: a new mechanism for the emphysema-like changes ob-
served in Fut8-deficient mice, J. Biochem. 145 (2009) 643–651.
7] D. Osumi, M. Takahashi, E. Miyoshi, S. Yokoe, S.H. Lee, K. Noda, S. Nakamori, J. Gu,
Y. Ikeda, Y. Kuroki, K. Sengoku, M. Ishikawa, N. Taniguchi, Core fucosylation of
E-cadherin enhances cell–cell adhesion in human colon carcinoma WiDr cells,
Cancer Sci. 100 (2009) 888–895.
8] Y. Zhao, S. Itoh, X. Wang, T. Isaji, E. Miyoshi, Y. Kariya, K. Miyazaki, N. Kawasaki, N.
Taniguchi, J. Gu, Deletion of core fucosylation on α3β1 integrin down-regulates
its functions, J. Biol. Chem. 281 (2006) 38343–38350.
9] K. Noda, E. Miyoshi, N. Uozumi, C.X. Gao, K. Suzuki, N. Hayashi, M. Hori, N.
Taniguchi, High expression of α1,6-fucosyltransferase during rat hepatocarcino-
genesis, Int. J. Cancer 75 (1998) 444–450.
10] K. Noda, E. Miyoshi, N. Uozumi, S. Yanagidani, Y. Ikeda, C. Gao, K. Suzuki, H.
Yoshihara, K. Yoshikawa, K. Kawano, N. Hayashi, M. Hori, N. Taniguchi, Gene ex-
pression of α1,6-fucosyltransferase in human hepatoma tissues: a possible impli-
cation for increased fucosylation of alpha-fetoprotein, Hepatology 28 (1998)
nificantly different from that proposed for the α1,3 fucosyltransferase
from H. pylori. Both enzymes have GT-B fold and a Rossman fold for
binding of the nucleotide. They differ, however, profoundly in their
overall 3D structure and in their sequence. Guanine is bound and
recognized by backbone carbonyl functions instead of an essential
aspartate. Furthermore, two positively charged residues (Arg195 and
Lys250) bind the pyrophosphate in addition to the backbone amides
of helices of the Rossman fold. Finally, an essential glutamate residue
[
[
(
Glu95) is properly positioned to take over the function of the base
catalyst. Such a residue is not present in FUT8.
[
5
. Conclusions
[
We performed ligand based NMR analysis in combination with in
[
silico methods to obtain a model of donor substrate binding of
human FUT8. The model of the complex provides detailed insight
into substrate–enzyme contacts and is consistent with our experi-
mental data from NMR and SPR studies and also with mutation studies
by Ihara et al. [27]. Our results suggest that GDP-Fuc is recognized in a
highly specific manner by hydrogen bonds of guanosine with the side
chain of the essential Asp453 and the side chain of His363. Binding af-
finity of the donor molecule to FUT8 is dependent on the β-phosphate
group as found by SPR experiments in our study. The model provides
the structural basis for this finding with multiple very stable hydrogen
bonds that the pyrophosphate moiety forms with the amide functions
of the backbones in the Rossman fold. The fucose moiety points to-
wards a shallow region that is able to accommodate the acceptor mol-
ecule of FUT8. Finally, our model gives implications for the role of the
essential Arg365: Besides binding of the β-phosphate, Arg365 assists
in GDP release and proper orientation of the fucose residue for nucle-
ophilic attack of the acceptor. The specific interactions of Arg365 and
of Gln470 with the fucose also ensure discrimination between GDP-
Fuc and GDP-Man. Our study provides information for structure-
based design of selective inhibitors of FUT8. Further studies are
aimed to extend our model to the binding of the acceptor substrate.
A model of the ternary complex however requires a profound model
on the FUT8/GDP-Fuc complex as presented here.
944–952.
[
[
[
11] K. Moriwaki, K. Noda, T. Nakagawa, M. Asahi, H. Yoshihara, N. Taniguchi, N.
Hayashi, E. Miyoshi, A high expression of GDP-fucose transporter in hepatocellu-
lar carcinoma is a key factor for increases in fucosylation, Glycobiology 17 (2007)
1311–1320.
12] R.L. Shields, J. Lai, R. Keck, L.Y. O'Connell, K. Hong, Y.G. Meng, S.H. Weikert, L.G.
Presta, Lack of fucose on human IgG1 N-linked oligosaccharide improves binding
to human Fcgamma RIII and antibody-dependent cellular toxicity, J. Biol. Chem.
277 (2002) 26733–26740.
13] T. Shinkawa, K. Nakamura, N. Yamane, E. Shoji-Hosaka, Y. Kanda, M. Sakurada, K.
Uchida, H. Anazawa, M. Satoh, M. Yamasaki, N. Hanai, K. Shitara, The absence of
fucose but not the presence of galactose or bisecting N-acetylglucosamine of
human IgG1 complex-type oligosaccharides shows the critical role of enhancing
antibody-dependent cellular cytotoxicity, J. Biol. Chem. 278 (2003) 3466–3473.
14] S. André, T. Kožár, S. Kojima, C. Unverzagt, H.-J. Gabius, From structural to func-
tional glycomics: core substitutions as molecular switches for shape and lectin af-
finity of N-glycans, Biol. Chem. 390 (2009) 557.
15] W. Nishima, N. Miyashita, Y. Yamaguchi, Y. Sugita, S. Re, Effect of bisecting GlcNAc
and core fucosylation on conformational properties of biantennary complex-type
N-glycans in solution, J. Phys. Chem. B 116 (2012) 8504–8512.
[16] K. Schaefer, J. Albers, N. Sindhuwinata, T. Peters, B. Meyer, A new concept for
glycosyltransferase inhibitors: nonionic mimics of the nucleotide donor of the
human blood group B galactosyltransferase, ChemBioChem 13 (2012) 443–450.
[
[
[
17] R.R. Schmidt, K.-H. Jung, Glycosyltransferase inhibitors, in: C.-H. Wong (Ed.),
Carbohydrate-based Drug Discovery, vol. 2, Wiley-VCH, Weinheim, 2003, pp. 609–659.
18] N. Uozumi, S. Yanagidani, E. Miyoshi, Y. Ihara, T. Sakuma, C.X. Gao, T. Teshima, S.
Fujii, T. Shiba, N. Taniguchi, Purification and cDNA cloning of porcine brain
GDP-L-Fuc:N-acetyl-β-D-glucosaminide α1,6-fucosyltransferase, J. Biol. Chem.
[
2
71 (1996) 27810–27817.
Acknowledgements
[
[
19] S. Yanagidani, N. Uozumi, Y. Ihara, E. Miyoshi, N. Yamaguchi, N. Taniguchi,
Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-β-D-glucosaminide:
α1,6-fucosyltransferase (α1,6 FucT) from human gastric cancer MKN45
cells, J. Biochem. 121 (1997) 626–632.
20] J.A. Voynow, R.S. Kaiser, T.F. Scanlin, M.C. Glick, Purification and characterization
of GDP-L-fucose-N-acetyl β-D-glucosaminide α1,6-fucosyltransferase from cul-
tured human skin fibroblasts. Requirement of a specific biantennary oligosaccha-
ride as substrate, J. Biol. Chem. 266 (1991) 21572–21577.
21] M. Costache, P.-A. Apoil, A. Cailleau, A. Elmgren, G. Larson, S. Henry, A. Blancher,
D. Iordachescu, R. Oriol, R. Mollicone, Evolution of fucosyltransferase genes in
vertebrates, J. Biol. Chem. 272 (1997) 29721–29728.
22] Y. Yamaguchi, Y. Ikeda, T. Takahashi, H. Ihara, T. Tanaka, C. Sasho, N. Uozumi, S.
Yanagidani, S. Inoue, J. Fujii, N. Taniguchi, Genomic structure and promoter analysis
of the human α1,6-fucosyltransferase gene (FUT8), Glycobiology 10 (2000) 637–643.
23] I. Martinez-Duncker, R. Mollicone, J.J. Candelier, C. Breton, R. Oriol, A new
superfamily of protein-O-fucosyltransferases, α2-fucosyltransferases, and α6-
fucosyltransferases: phylogeny and identification of conserved peptide motifs,
Glycobiology 13 (2003) 1C–5C.
We thank the Deutsche Forschungsgemeinschaft for a grant for
the 700 MHz NMR (Me 1830/1). This work was supported by the
Hamburg School of Structure and Dynamics in Infection (SDI). We
thank Martin Wienke and Beatrice Jürs for their assistance with the
molecular modeling software.
[
[
[
Appendix A. Supplementary material
References
[24] C. Breton, R. Oriol, A. Imberty, Conserved structural features in eukaryotic and
prokaryotic fucosyltransferases, Glycobiology 8 (1998) 87–94.
[
1] J.R. Wilson, D. Williams, H. Schachter, Control of glycoprotein synthesis—
N-acetylglucosamine linkage to a mannose residue as a signal for attachment of
L-fucose to asparagine-linked N-acetylglucosamine residue of glycopeptide from
α1-acid glycoprotein, Biochem. Biophys. Res. Commun. 72 (1976) 909–916.
2] E. Miyoshi, K. Noda, Y. Yamaguchi, S. Inoue, Y. Ikeda, W. Wang, J.H. Ko, N. Uozumi,
W. Li, N. Taniguchi, The α1,6-fucosyltransferase gene and its biological signifi-
cance, Biochim. Biophys. Acta 1473 (1999) 9–20.
[25] R. Oriol, R. Mollicone, A. Cailleau, L. Balanzino, C. Breton, Divergent evolution
of fucosyltransferase genes from vertebrates, invertebrates, and bacteria,
Glycobiology 9 (1999) 323–334.
[26] T. Takahashi, Y. Ikeda, A. Tateishi, Y. Yamaguchi, M. Ishikawa, N. Taniguchi, A se-
quence motif involved in the donor substrate binding by α1,6-fucosyltransferase:
the role of the conserved arginine residues, Glycobiology 10 (2000) 503–510.
[27] H. Ihara, Y. Ikeda, N. Taniguchi, Reaction mechanism and substrate specificity for
nucleotide sugar of mammalian α1,6-fucosyltransferase—a large-scale prepara-
tion and characterization of recombinant human FUT8, Glycobiology 16 (2006)
333–342.
[
[
3] M. Takahashi, Y. Kuroki, K. Ohtsubo, N. Taniguchi, Core fucose and bisecting
GlcNAc, the direct modifiers of the N-glycan core: their functions and target pro-
teins, Carbohydr. Res. 344 (2009) 1387–1390.